Single-source drug submissions under review
Information on the status of manufacturers' drug submissions that allows industry stakeholders and the public to track the status of drug submissions through the various stages of the review cycle.
Use the data API
Visualize data
Use the Data Visualizer below to display this dataset as a table, graph or map.
Report an issue with this data
Submit a report if you are experiencing issues with the data resources in this dataset.
Data dictionary
Column | Type | Description |
---|---|---|
Brand Name | Text |
Drug brand name |
Generic Name | Text |
Drug generic name |
Strength and Format | Text |
Strength and format of drug |
Manufacturer | Text |
Drug manufacturer |
Indication | Text |
Drug indication |
Date submission was deemed complete | Date |
Date drug submission was deemed complete |
Review Status | Text |
Review status of drug |
Additional information
- Last updated
- January 23, 2025
- Created
- October 20, 2023
- Format
- application/csv
- File size
- 11.3 KiB
- Licence
- Open Government Licence – Ontario
- Name
- Single-source drug submissions under review
- Type
- Data
- Language
- English
- Data made public date
- October 20, 2023
- Data range start
- April 8, 2021
- Data range end
- December 31, 2024
- Validation status
- success
- Validation timestamp
- 2025-01-23T18:52:28.094512
Help us improve the Data Catalogue
Provide feedback about our data and how you’re using it.